ATE181734T1 - N-benzoylmethylsubstituierte paroxetinderivate - Google Patents
N-benzoylmethylsubstituierte paroxetinderivateInfo
- Publication number
- ATE181734T1 ATE181734T1 AT95928869T AT95928869T ATE181734T1 AT E181734 T1 ATE181734 T1 AT E181734T1 AT 95928869 T AT95928869 T AT 95928869T AT 95928869 T AT95928869 T AT 95928869T AT E181734 T1 ATE181734 T1 AT E181734T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- benzoylmethyl
- substituted
- sec
- date
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical class C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- VOIKTEMGYNKRTL-UHFFFAOYSA-N 1-phenyl-2-piperidin-1-ylethanone Chemical class C=1C=CC=CC=1C(=O)CN1CCCCC1 VOIKTEMGYNKRTL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09400582A ES2102295B1 (es) | 1994-03-18 | 1994-03-18 | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181734T1 true ATE181734T1 (de) | 1999-07-15 |
Family
ID=8285616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95928869T ATE181734T1 (de) | 1994-03-18 | 1995-03-17 | N-benzoylmethylsubstituierte paroxetinderivate |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5665736A (de) |
| EP (1) | EP0699198B1 (de) |
| JP (1) | JP3213324B2 (de) |
| KR (1) | KR0182093B1 (de) |
| AT (1) | ATE181734T1 (de) |
| AU (1) | AU678320B2 (de) |
| CA (1) | CA2163253C (de) |
| DE (1) | DE69510510T2 (de) |
| DK (1) | DK0699198T3 (de) |
| ES (1) | ES2102295B1 (de) |
| FI (1) | FI108862B (de) |
| GR (1) | GR3031282T3 (de) |
| IL (1) | IL112763A (de) |
| NO (1) | NO308002B1 (de) |
| NZ (1) | NZ283130A (de) |
| PH (1) | PH31388A (de) |
| TW (1) | TW416956B (de) |
| WO (1) | WO1995025732A1 (de) |
| ZA (1) | ZA951963B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
| EP1394160A1 (de) | 1996-06-13 | 2004-03-03 | SUMIKA FINE CHEMICALS Co., Ltd. | Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid |
| GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
| GB9700690D0 (en) | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
| EP0986389B1 (de) * | 1997-05-29 | 2004-10-13 | Smithkline Beecham Corporation | Neues verfahren |
| GB9826175D0 (en) * | 1998-11-28 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| EP1318988A2 (de) * | 2000-09-11 | 2003-06-18 | Sepracor, Inc. | Liganden für monoamin rezeptoren und transporter, und verwendungsmethoden dafür (neurotransmission) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| EP0190496A3 (de) * | 1984-12-13 | 1987-05-27 | Beecham Group Plc | Piperidinderivate mit gastro-intestinaler Wirkung |
| EP0223403B1 (de) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel |
| DK231088D0 (da) * | 1988-04-28 | 1988-04-28 | Ferrosan As | Piperidinforbindelser, deres fremstilling og anvendelse |
| IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
| US5017585A (en) * | 1986-11-03 | 1991-05-21 | Novo Nordisk A/S | Method of treating calcium overload |
-
1994
- 1994-03-18 ES ES09400582A patent/ES2102295B1/es not_active Expired - Fee Related
-
1995
- 1995-02-21 TW TW084101572A patent/TW416956B/zh active
- 1995-02-23 IL IL112763A patent/IL112763A/en not_active IP Right Cessation
- 1995-02-27 PH PH51032A patent/PH31388A/en unknown
- 1995-03-09 ZA ZA951963A patent/ZA951963B/xx unknown
- 1995-03-17 WO PCT/EP1995/001007 patent/WO1995025732A1/en not_active Ceased
- 1995-03-17 CA CA002163253A patent/CA2163253C/en not_active Expired - Fee Related
- 1995-03-17 EP EP95928869A patent/EP0699198B1/de not_active Expired - Lifetime
- 1995-03-17 US US08/557,008 patent/US5665736A/en not_active Expired - Fee Related
- 1995-03-17 KR KR1019950705161A patent/KR0182093B1/ko not_active Expired - Fee Related
- 1995-03-17 DE DE69510510T patent/DE69510510T2/de not_active Expired - Fee Related
- 1995-03-17 AU AU21094/95A patent/AU678320B2/en not_active Ceased
- 1995-03-17 AT AT95928869T patent/ATE181734T1/de not_active IP Right Cessation
- 1995-03-17 DK DK95928869T patent/DK0699198T3/da active
- 1995-03-17 JP JP52437595A patent/JP3213324B2/ja not_active Expired - Fee Related
- 1995-03-17 NZ NZ283130A patent/NZ283130A/en unknown
- 1995-11-08 FI FI955387A patent/FI108862B/fi not_active IP Right Cessation
- 1995-11-10 NO NO954538A patent/NO308002B1/no unknown
-
1999
- 1999-09-22 GR GR990402380T patent/GR3031282T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU678320B2 (en) | 1997-05-22 |
| NO954538D0 (no) | 1995-11-10 |
| NO954538L (no) | 1995-11-10 |
| NZ283130A (en) | 1996-11-26 |
| PH31388A (en) | 1998-10-29 |
| IL112763A0 (en) | 1995-05-26 |
| TW416956B (en) | 2001-01-01 |
| JPH08510477A (ja) | 1996-11-05 |
| IL112763A (en) | 1998-03-10 |
| AU2109495A (en) | 1995-10-09 |
| WO1995025732A1 (en) | 1995-09-28 |
| DE69510510D1 (de) | 1999-08-05 |
| CA2163253A1 (en) | 1995-09-28 |
| ES2102295A1 (es) | 1997-07-16 |
| CA2163253C (en) | 2004-08-10 |
| JP3213324B2 (ja) | 2001-10-02 |
| EP0699198B1 (de) | 1999-06-30 |
| US5665736A (en) | 1997-09-09 |
| EP0699198A1 (de) | 1996-03-06 |
| DK0699198T3 (da) | 1999-11-22 |
| FI955387A0 (fi) | 1995-11-08 |
| NO308002B1 (no) | 2000-07-03 |
| ZA951963B (en) | 1996-03-11 |
| DE69510510T2 (de) | 1999-11-18 |
| GR3031282T3 (en) | 1999-12-31 |
| KR960702456A (ko) | 1996-04-27 |
| FI108862B (fi) | 2002-04-15 |
| ES2102295B1 (es) | 1998-04-01 |
| FI955387L (fi) | 1995-11-08 |
| KR0182093B1 (ko) | 1999-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| ES2194202T3 (es) | Compuestos polimorfos. | |
| ATE181734T1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| ES2191341T3 (es) | Derivados de la 2-fenoxianilina. | |
| NO970474D0 (no) | N-substituerte azabicykloheptan-derivater egnet som neuroleptika | |
| DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
| DK0720598T3 (da) | Phenoxyphenylcyclopentenyl-hydroxyurinstoffer | |
| FI955386A0 (fi) | 4-p-fluoribentsoyyli-1-piperidinyyli-propoksi-kromen-4-onijohdannaiset, niiden valmistus ja käyttö psykoosin ja skitsofrenian hoidossa | |
| AU5125798A (en) | Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use | |
| ZA9480B (en) | Pyrrolidine derivatives their preparation and medicaments containing them | |
| NO306673B1 (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse | |
| DK0871611T3 (da) | Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |